Dr. Nancy Speck, Chair and Professor of Cell and Developmental Biology, and Program Co-Leader in the IRM’s Hematopoietic Stem Cells program, was recently elected to the National Academy of the Sciences. Dr. Speck’s career has included significant discoveries concerning mutations in the proteins RUNX1 and CBFβ, both associated with leukemia.
She is also co-leader of the Hematologic Malignancies Program at the Abramson Cancer Center and is an investigator in the Abramson Family Cancer Research Institute. Our enthusiastic congratulations go out to Dr. Speck!
Read more at Penn Today…
